Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085608196> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3085608196 endingPage "25" @default.
- W3085608196 startingPage "1" @default.
- W3085608196 abstract "FLT180a is an investigational gene therapy medicinal product candidate intended for treating HB patients It includes a novel synthetic capsid, AAVS3, with a higher liver transduction efficiency than wild type AAV, and a codon optimised F9 gene with a gain of function mutation To assess the safety and efficacy of a single systemic adminis-tration of FLT180a in adult patients with HB Phase 1/2, multi- centre, ongoing, open- label and long- term follow- up study assessing FLT180a dose levels in an escalating/descending adaptive design, to identify a dose that consistently normalises FIX activity (50- 150%) Participants have severe or moderately severe HB and are negative for neutralis-ing AAVS3 antibodies Pre- emptive immunosuppression is given to mitigate vector related transaminitis and associated reduction in FIX expression Ten patients with severe HB have been treated across 4 dose levels, with week 3 FIX activity levels ranging between 24 and 168% The first two patients, receiving the 4 5e11vg/Kg dose, have stable, therapeutic, FIX activity levels through week 104 No patient has had a bleeding episode requiring FIX concentrates The most common drug related serious adverse event was transient transaminitis (in four patients) requiring supplemental immunosup-pression FIX activity levels above 150% have been observed, which were individually assessed for risk of thrombosis, and one patient is being treated with DOACs Refinement of the immunosuppression regimen for the latest three patients (9 75e11 vg/kg dose) prevented transaminitis during the critical phase (4- 16 weeks) FLT180a achieves clinically meaningful, dura-ble FIX activity levels in patients with HB, associated with in-dependence from FIX replacement therapy and zero treated bleeds Transient transaminitis was largely averted by prophy-lactic immunosuppression A dose between 7 5 to 9 75e11vg/Kg can potentially create sustained, normal FIX activity levels in patients with severe HB" @default.
- W3085608196 created "2020-09-21" @default.
- W3085608196 creator A5001296013 @default.
- W3085608196 creator A5013825377 @default.
- W3085608196 creator A5022609560 @default.
- W3085608196 creator A5032382336 @default.
- W3085608196 creator A5033254119 @default.
- W3085608196 creator A5035072449 @default.
- W3085608196 creator A5035469816 @default.
- W3085608196 creator A5054188186 @default.
- W3085608196 creator A5056195915 @default.
- W3085608196 creator A5061166849 @default.
- W3085608196 creator A5068415698 @default.
- W3085608196 creator A5069780384 @default.
- W3085608196 creator A5071670444 @default.
- W3085608196 creator A5073344415 @default.
- W3085608196 creator A5079367804 @default.
- W3085608196 creator A5082474188 @default.
- W3085608196 creator A5087411937 @default.
- W3085608196 creator A5089578564 @default.
- W3085608196 date "2020-01-01" @default.
- W3085608196 modified "2023-09-26" @default.
- W3085608196 title "LATE-BREAKING AND COVID-19 ORAL COMMUNICATION SESSION ABSTRACTS" @default.
- W3085608196 hasPublicationYear "2020" @default.
- W3085608196 type Work @default.
- W3085608196 sameAs 3085608196 @default.
- W3085608196 citedByCount "0" @default.
- W3085608196 crossrefType "journal-article" @default.
- W3085608196 hasAuthorship W3085608196A5001296013 @default.
- W3085608196 hasAuthorship W3085608196A5013825377 @default.
- W3085608196 hasAuthorship W3085608196A5022609560 @default.
- W3085608196 hasAuthorship W3085608196A5032382336 @default.
- W3085608196 hasAuthorship W3085608196A5033254119 @default.
- W3085608196 hasAuthorship W3085608196A5035072449 @default.
- W3085608196 hasAuthorship W3085608196A5035469816 @default.
- W3085608196 hasAuthorship W3085608196A5054188186 @default.
- W3085608196 hasAuthorship W3085608196A5056195915 @default.
- W3085608196 hasAuthorship W3085608196A5061166849 @default.
- W3085608196 hasAuthorship W3085608196A5068415698 @default.
- W3085608196 hasAuthorship W3085608196A5069780384 @default.
- W3085608196 hasAuthorship W3085608196A5071670444 @default.
- W3085608196 hasAuthorship W3085608196A5073344415 @default.
- W3085608196 hasAuthorship W3085608196A5079367804 @default.
- W3085608196 hasAuthorship W3085608196A5082474188 @default.
- W3085608196 hasAuthorship W3085608196A5087411937 @default.
- W3085608196 hasAuthorship W3085608196A5089578564 @default.
- W3085608196 hasConcept C126322002 @default.
- W3085608196 hasConcept C197934379 @default.
- W3085608196 hasConcept C2780252810 @default.
- W3085608196 hasConcept C2781413609 @default.
- W3085608196 hasConcept C71924100 @default.
- W3085608196 hasConceptScore W3085608196C126322002 @default.
- W3085608196 hasConceptScore W3085608196C197934379 @default.
- W3085608196 hasConceptScore W3085608196C2780252810 @default.
- W3085608196 hasConceptScore W3085608196C2781413609 @default.
- W3085608196 hasConceptScore W3085608196C71924100 @default.
- W3085608196 hasLocation W30856081961 @default.
- W3085608196 hasOpenAccess W3085608196 @default.
- W3085608196 hasPrimaryLocation W30856081961 @default.
- W3085608196 hasRelatedWork W1275118541 @default.
- W3085608196 hasRelatedWork W1587817350 @default.
- W3085608196 hasRelatedWork W1952469660 @default.
- W3085608196 hasRelatedWork W1998235810 @default.
- W3085608196 hasRelatedWork W2014823754 @default.
- W3085608196 hasRelatedWork W2026951503 @default.
- W3085608196 hasRelatedWork W2146002704 @default.
- W3085608196 hasRelatedWork W2146397692 @default.
- W3085608196 hasRelatedWork W2167780095 @default.
- W3085608196 hasRelatedWork W2245043935 @default.
- W3085608196 hasRelatedWork W2317100255 @default.
- W3085608196 hasRelatedWork W2319686098 @default.
- W3085608196 hasRelatedWork W2383509631 @default.
- W3085608196 hasRelatedWork W2618945960 @default.
- W3085608196 hasRelatedWork W3014735311 @default.
- W3085608196 hasRelatedWork W3082747704 @default.
- W3085608196 hasRelatedWork W3213911264 @default.
- W3085608196 hasRelatedWork W58252485 @default.
- W3085608196 hasRelatedWork W3140349538 @default.
- W3085608196 hasRelatedWork W3146567634 @default.
- W3085608196 hasVolume "4" @default.
- W3085608196 isParatext "false" @default.
- W3085608196 isRetracted "false" @default.
- W3085608196 magId "3085608196" @default.
- W3085608196 workType "article" @default.